4.7 Article

Discovery of New Inhibitors of D-Alanine:D-Alanine Ligase by Structure-Based Virtual Screening

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 23, Pages 7442-7448

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm800726b

Keywords

-

Funding

  1. Ministry of Higher Education, Science, and Technology of the Republic of Slovenia
  2. Slovenian Research Agency

Ask authors/readers for more resources

The terminal dipeptide, D-Ala-D-Ala, of the peptidoglycan precursor UDPMurNAc-pentapetide is a crucial building block involved in peptidoglycan cross-linking. It is synthesized in the bacterial cytoplasm by the enzyme D-alanine:D-alanine ligase (Ddl). Structure-based virtual screening of the NCI diversity set of almost 2000 compounds was performed with a Dd1B isoform from Escherichia coli using the computational tool AutoDock 4.0. The 130 best-ranked compounds from this screen were tested in an in vitro assay for their inhibition of E. coli DdlB. Three compounds were identified that inhibit the enzyme with K-i values in micromolar range. Two of these also have promising antibacterial activities against Gram-positive and Gram-negative bacteria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available